Connect with us

Hi, what are you looking for?

Business

Israel’s Teva reaches potential $4.25 bn US opioid settlement

Israeli generic drug maker Teva has reached an agreement in principle to pay $4.25 billion over 13 years to settle a series of court cases.

US judge approves deal dissolving Purdue Pharma in opioid saga
Image: © AFP Noel Celis
Image: © AFP Noel Celis

Israeli generic drug maker Teva has reached an agreement in principle to pay $4.25 billion over 13 years to settle a series of court cases over its role in the US opioid epidemic.

If the deal is finalized, Teva would become the latest major company to reach a settlement over the crisis which caused hundreds of thousands of deaths and ravaged communities across the country.

“Teva has reached an agreement in principle with the working group of states’ attorneys general, counsel for Native American tribes, and plaintiff’s lawyers representing the states and subdivisions, on the primary financial terms of a nationwide opioids settlement,” the company said in its second-quarter financial results.

“Teva will pay up to $4.25 billion (including the already settled cases) plus approximately $100 million for the tribes, spread over 13 years,” it said.

The overall figure includes up to $1.2 billion in the generic version of Narcan, which can reverse opioid overdoses.

The deal will include “no admission of wrongdoing,” the company said.

Teva has already gone through several opioid-related lawsuits and reached agreements with some states.

The opioid crisis, which has caused more than 500,000 deaths over 20 years in the United States, has triggered a flurry of lawsuits from victims as well as cities, counties and states impacted by the fallout.

Drugmaker Johnson & Johnson and three major distributors, McKesson, AmerisourceBergen and Cardinal Health, have agreed to pay out $24.5 billion over several years to end more than 3,000 lawsuits.

Purdue Pharma, considered by many to be a major driver of the crisis because of its aggressive promotion of its pain killer OxyContin, filed for bankruptcy in September 2019 as it faced a flood of legal action.

AFP
Written By

With 2,400 staff representing 100 different nationalities, AFP covers the world as a leading global news agency. AFP provides fast, comprehensive and verified coverage of the issues affecting our daily lives.

You may also like:

Business

In March, prices rocketed to more than $10,000 a tonne in New York after a poor harvest in West Africa.

World

Medical team members evacuate a Muslim pilgrim, affected by the soarching heat, at the base of Mount Arafat, also known as Jabal al-Rahma or...

Tech & Science

It was also found that the relationship between genotype and phenotype is more different than the relationship between coffee and tea.

Tech & Science

Results from the study with an enveloped coronavirus showed that pine, spruce, birch and alder need one hour to completely reduce the virus' ability...